Press Releases

WASHINGTON, DC, May 13, 2016—WomenAgainstAlzheimer’s – an UsAgainstAlzheimer’s network and a global nonprofit organization that advocates for women – today announced the launch of its bold We Won’t Wait campaign to bring to light the economic injustice that women face when they experience Alzheimer’s either as the patient or the caregiver. The campaign is the first-ever effort to define Alzheimer’s as both an economic as well as a health-related injustice against women, and it is the organization’s next phase in its successful work over the last four years fighting for a cure through a woman’s lens. 

WASHINGTON, DC, May 12, 2016—Today, UsAgainstAlzheimer’s announced that Jason Resendez, Director of UsAgainstAlzheimer’s Latino Network and the LatinosAgainstAlzheimer’s Coalition, will join AT&T’s Advisory Panel on Access and Aging as an external advisor. 

UsAgainstAlzheimer’s (UsA2) co-founders, George and Trish Vradenburg, as well as UsA2 network leads Jill Lesser (WomenAgainstAlzheimer’s), Jason Resendez (LatinosAgainstAlzheimer’s), Drew Holzapfel (ResearchersAgainstAlzheimer’s) and Virginia Biggar (ClergyAgainstAlzheimer’s) will be guests on today’s Alzheimer’s Speaks Radio show, hosted by Lori La Bey, at 2 pm EST.

WASHINGTON, DC – UsAgainstAlzheimer’s (UsA2) co-founders George and Trish Vradenburg were honored today at the Sixth Annual Great Ladies Luncheon & Fashion Show, presented by the Alzheimer’s Drug Discovery Foundation (ADDF) and Neiman Marcus Mazza Gallerie, for their many contributions to ending Alzheimer’s disease. The event, emceed by Fox News television anchor Chris Wallace, featured a presentation on “New Frontiers in Alzheimer’s Prevention and Treatment,” as well as a runway show by Oscar de la Renta.

WASHINGTON, DC—Following is a statement by George Vradenburg, chairman of UsAgainstAlzheimer's, on the announcement that Eli Lilly and Company and AstraZeneca's experimental BACE inhibitor drug for Alzheimer's is advancing to Phase 3 clinical trials


^ Back to Top